IM Cannabis
Update in progressIMCC (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
IM Cannabis Corp. imports, distributes and sells medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers and full-spectrum cannabis extracts under the IMC, BLKMT and LOT420 brands, serving medical patients. Founded in 2008, the company is headquartered in British Columbia, Canada.
Company score
- Sentiment
- 0.15
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- -0.04
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.01
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.07
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationCanada
- CEOMr. Oren Shuster
- Founded2008
- Employees44
- Websiteimcannabis.com
Identifiers
- ISINCA44969Q2080
- FIGIBBG00TZRCZB5
- CUSIP449923101
- CIK0001792030